RDY research · 13F holders by reporting quarter
DR Reddys Laboratories LTD (RDY): 13F holders, 2026Q2
The largest share positions in RDY that the managers Kresmion follows reported on Form 13F for 2026Q2, as filed. The current quarter, the company's SEC filings and its recent events are on the RDY research page.
RDY positions held by the managers we follow (2026Q2)
What the managers we follow bought and sold in Q3 2026
| Manager / security | Market value | % of reported value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC FundCUSIP 256135203 · 2026Q2 | $106.5M | 0.15% |
| MILLENNIUM MANAGEMENT LLC FundCUSIP 256135203 · 2026Q2 | $6.8M | 0.00% |
| D. E. Shaw & Co., Inc. FundCUSIP 256135203 · 2026Q2 | $1.8M | 0.00% |
| CITADEL ADVISORS LLC FundCUSIP 256135203 · 2026Q2 | $1.1M | 0.00% |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. A Form 13F-HR is due 45 days after the quarter ends, or on the next business day when that day falls on a weekend or a US federal holiday.